je.st
news
Tag: gilead sciences
Q1 2016 EPS Estimates for Gilead Sciences, Inc. (GILD) Lifted by Leerink Partner
2016-04-14 04:02:18| Biotech - Topix.net
Gilead Sciences, Inc. - Analysts at Leerink Partner lifted their Q1 2016 earnings per share estimates for Gilead Sciences in a note issued to investors on Thursday, according to Zacks Investment Research . Leerink Partner analyst G. Porges now expects that the brokerage will earn $3.29 per share for the quarter, up from their prior forecast of $3.08.
Tags: partner
sciences
estimates
eps
Gilead Sciences, Inc. (GILD) Rating Reiterated by Mizuho
2016-04-10 23:14:22| Biotech - Topix.net
's stock had its "buy" rating reaffirmed by investment analysts at Mizuho in a research report issued on Sunday, Marketbeat.com reports. They presently have a $130.00 target price on the biopharmaceutical company's stock.
Tags: rating
sciences
gilead
mizuho
Gilead Sciences, Inc. (GILD) Downgraded by Vetr Inc. to "Buy"
2016-04-04 08:36:27| Biotech - Topix.net
They presently have a $104.96 target price on the biopharmaceutical company's stock. Vetr 's target price would suggest a potential upside of 11.52% from the stock's current price.
Tags: to
buy
sciences
downgraded
Gilead Sciences Vs. Its Peers
2016-03-30 15:05:36| Biotech - Topix.net
Normally when I look at companies that have a market cap over 100 billion USD they are either growth stocks with sky-high PEs or 'boring', high dividend paying companies that have been around for decades. Gilead Sciences GILD was founded by Michael Riordan in California almost 29 years ago.
Tags: sciences
peers
gilead
gilead sciences
Jefferies Group Reiterates Hold Rating for Gilead Sciences, Inc.
2016-03-27 07:36:47| Biotech - Topix.net
's stock had its "hold" rating reiterated by investment analysts at Jefferies Group in a report issued on Monday, Market Beat Ratings reports. They currently have a $97.00 price target on the biopharmaceutical company's stock, down from their prior price target of $100.00.